William Herrington1,2, Nicola Illingworth3,4, Natalie Staplin3, Aishwarya Kumar3,4, Ben Storey3,2,4, Renata Hrusecka3,4, Parminder Judge3,2,4, Maria Mahmood2, Sarah Parish3,4, Martin Landray3, Richard Haynes3,2,4, Colin Baigent3,4, Michael Hill3,4, Sarah Clark3,4. 1. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Oxford, United Kingdom; will.herrington@ndph.ox.ac.uk. 2. Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; and. 3. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Oxford, United Kingdom. 4. Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, Oxford, United Kingdom.
Abstract
BACKGROUND AND OBJECTIVES: Because there is substantial biologic intraindividual variation in albumin excretion, randomized trials of albuminuria-reducing therapies may need multiple urine samples to estimate daily urinary albumin excretion. Mailing spot urine samples could offer a convenient and cost-effective method to collect multiple samples, but urine albumin-to-creatinine ratio stability in samples stored at ambient temperatures for several days is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with kidney disease provided fresh urine samples in two tubes (with and without boric acid preservative). Reference aliquots from each participant were analyzed immediately, whereas remaining aliquots were subject to different handling/storage conditions before analysis, including delayed processing for up to 7 days at three different storage temperatures (4°C, 18°C, and 30°C), multiple freeze-thaw cycles, and long-term frozen storage at -80°C, -40°C, and -20°C. We calculated the mean percentage change in urine albumin-to-creatinine ratio for each condition, and we considered samples stable if the 95% confidence interval was within a ±5% threshold. RESULTS: Ninety-three patients provided samples with detectable albuminuria in the reference aliquot. Median (interquartile range) urine albumin-to-creatinine ratio was 87 (20-499) mg/g. The inclusion of preservative had minimal effect on fresh urine albumin-to-creatinine ratio measurements but reduced the changes in albumin and creatinine in samples subject to processing delay and storage conditions. The urine albumin-to-creatinine ratio was stable for 7 days in samples containing preservative at 4°C and 18°C and 2 days when stored at 30°C. It was also stable in samples with preservative after three freeze-thaw cycles and in frozen storage for 6 months at -80°C or -40°C but not at -20°C. CONCLUSIONS: Mailed urine samples collected with preservative and received within 7 days if ambient temperature is ≤18°C, or within 2 days if the temperature is higher but does not exceed 30°C, are suitable for the measurement of urine albumin-to-creatinine ratio in randomized trials. Preserved samples frozen to -40°C or -80°C for 6 months before analysis also seem suitable.
BACKGROUND AND OBJECTIVES: Because there is substantial biologic intraindividual variation in albumin excretion, randomized trials of albuminuria-reducing therapies may need multiple urine samples to estimate daily urinary albumin excretion. Mailing spot urine samples could offer a convenient and cost-effective method to collect multiple samples, but urine albumin-to-creatinine ratio stability in samples stored at ambient temperatures for several days is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with kidney disease provided fresh urine samples in two tubes (with and without boric acid preservative). Reference aliquots from each participant were analyzed immediately, whereas remaining aliquots were subject to different handling/storage conditions before analysis, including delayed processing for up to 7 days at three different storage temperatures (4°C, 18°C, and 30°C), multiple freeze-thaw cycles, and long-term frozen storage at -80°C, -40°C, and -20°C. We calculated the mean percentage change in urine albumin-to-creatinine ratio for each condition, and we considered samples stable if the 95% confidence interval was within a ±5% threshold. RESULTS: Ninety-three patients provided samples with detectable albuminuria in the reference aliquot. Median (interquartile range) urine albumin-to-creatinine ratio was 87 (20-499) mg/g. The inclusion of preservative had minimal effect on fresh urine albumin-to-creatinine ratio measurements but reduced the changes in albumin and creatinine in samples subject to processing delay and storage conditions. The urine albumin-to-creatinine ratio was stable for 7 days in samples containing preservative at 4°C and 18°C and 2 days when stored at 30°C. It was also stable in samples with preservative after three freeze-thaw cycles and in frozen storage for 6 months at -80°C or -40°C but not at -20°C. CONCLUSIONS: Mailed urine samples collected with preservative and received within 7 days if ambient temperature is ≤18°C, or within 2 days if the temperature is higher but does not exceed 30°C, are suitable for the measurement of urine albumin-to-creatinine ratio in randomized trials. Preserved samples frozen to -40°C or -80°C for 6 months before analysis also seem suitable.
Authors: Jacoline W Brinkman; Dick de Zeeuw; Jacko J Duker; Ronald T Gansevoort; Ido P Kema; Hans L Hillege; Paul E de Jong; Stephan J L Bakker Journal: Clin Chem Date: 2005-11 Impact factor: 8.327
Authors: Elsbeth C Witte; Hiddo J Lambers Heerspink; Dick de Zeeuw; Stephan J L Bakker; Paul E de Jong; Ronald Gansevoort Journal: J Am Soc Nephrol Date: 2008-12-17 Impact factor: 10.121
Authors: June Fabian; Jaya A George; Sean D Currin; Mwawi S Gondwe; Nokthula B Mayindi; Shingirai Chipungu; Bongekile L Khoza; Stephen Tollman Journal: BMC Nephrol Date: 2021-03-20 Impact factor: 2.388
Authors: Laura E Lamb; Joseph J Janicki; Sarah N Bartolone; Kenneth M Peters; Michael B Chancellor Journal: PLoS One Date: 2017-10-31 Impact factor: 3.240
Authors: Sophie Marielle van den Belt; Valentina Gracchi; Dick de Zeeuw; Hiddo Jan Lambers Heerspink Journal: PLoS One Date: 2018-06-21 Impact factor: 3.240
Authors: Hannah J Harjen; Tove V Nicolaysen; Tale Negard; Hege Lund; Bente K Sævik; Kristin P Anfinsen; Elena R Moldal; Karin E Zimmer; Runa Rørtveit Journal: BMC Vet Res Date: 2021-04-12 Impact factor: 2.741
Authors: Hee-Sung Ahn; Jong Ho Kim; Hwangkyo Jeong; Jiyoung Yu; Jeonghun Yeom; Sang Heon Song; Sang Soo Kim; In Joo Kim; Kyunggon Kim Journal: Int J Mol Sci Date: 2020-06-14 Impact factor: 5.923